BRIEF published on 06/18/2024 at 13:52, 1 year 10 months ago Heidelberg Pharma AG Announces Updated Guidance for 2024 Revenue Forecast Financial Guidance Biotech Heidelberg Pharma AG Operating Expenses
BRIEF published on 06/18/2024 at 13:52, 1 year 10 months ago Heidelberg Pharma AG annonce des prévisions mises à jour pour 2024 Conseils Financiers Prévisions De Revenus Heidelberg Pharma SA Biotechnologies Dépenses De Fonctionnement
PRESS RELEASE published on 06/18/2024 at 13:47, 1 year 10 months ago EQS-Adhoc: Heidelberg Pharma AG announces updated guidance Heidelberg Pharma AG updates guidance for fiscal year 2024, lowering sales expectations due to delays and adjusting operating expenses. Financing secured until mid-2025 with potential expansion until end of 2026 Financial Year 2024 Heidelberg Pharma AG Operating Expenses Sales Expectations Updated Guidance
BRIEF published on 05/23/2024 at 09:17, 1 year 11 months ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Cancer Treatment Conférences Heidelberg Pharma HDP-101 ADCs
BRIEF published on 05/23/2024 at 09:17, 1 year 11 months ago Heidelberg Pharma participera et présentera des conférences scientifiques de premier plan à venir en mai et juin 2024 Conférences Traitement Du Cancer Heidelberg Pharma HDP-101 ADC
PRESS RELEASE published on 05/23/2024 at 09:12, 1 year 11 months ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Heidelberg Pharma AG to participate and present at leading scientific conferences in May and June 2024, showcasing innovative ADC technology platforms for cancer treatment Cancer Treatment ADC Technology Heidelberg Pharma AG Scientific Conferences Clinical Stage Biotech
BRIEF published on 04/25/2024 at 07:26, 2 years ago Heidelberg Pharma AG Reports on Q1 2024 Financials and Operational Progress Financial Performance CEO Appointment Heidelberg Pharma AG HDP-101 Clinical Trial ADC Pipeline Development
BRIEF published on 04/25/2024 at 07:26, 2 years ago Heidelberg Pharma AG publie ses résultats financiers et ses progrès opérationnels pour le premier trimestre 2024 Performance Financière Nomination Du PDG Heidelberg Pharma SA Essai Clinique HDP-101 Développement Du Pipeline ADC
PRESS RELEASE published on 04/25/2024 at 07:21, 2 years ago Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024 Heidelberg Pharma AG reports on its interim management statement for the first three months of 2024, including first efficacy data from a clinical trial and successful financing activities Clinical Trial Heidelberg Pharma AG ADC Pipeline Interim Statement Financing Activities
BRIEF published on 04/05/2024 at 09:35, 2 years 1 month ago Heidelberg Pharma to Convene R&D Webinar to Share New Cancer Research Insights Heidelberg Pharma HDP-101 Multiple Myeloma ADCs R&D Webinar
Published on 05/13/2026 at 15:30, 3 hours 24 minutes ago All Things Mobile Analytic, Inc. (OTCID:ATMH) Acquires Metis Technology S.p.A., Strengthening European Enterprise Capabilities
Published on 05/13/2026 at 15:05, 3 hours 49 minutes ago Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services
Published on 05/13/2026 at 15:00, 3 hours 54 minutes ago ACCESS Newswire to Present at the LD Micro Invitational XVI on May 19th, at 2:00 pm ET
Published on 05/13/2026 at 15:00, 3 hours 54 minutes ago Caldwell Announces Relaunch of Canada's Top 40 Under 40(R) Award Program
Published on 05/13/2026 at 14:35, 4 hours 19 minutes ago INEO Announces Patented INEO Welcoming DUO in Full Production with First Installation Underway in Leading UK Retailer
Published on 05/13/2026 at 18:15, 39 minutes ago Africa Energy Forum 2026: Building Africa's Industrialised Future
Published on 05/13/2026 at 18:15, 39 minutes ago Africa Energy Forum 2026 : Construire l’avenir industrialisé de l’Afrique
Published on 05/13/2026 at 18:00, 54 minutes ago CGTN: How China helps advance girls' and women's education worldwide
Published on 05/13/2026 at 18:00, 54 minutes ago Private Equity Holding AG: Net Asset Value as of April 30, 2026
Published on 05/13/2026 at 18:02, 52 minutes ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 54 minutes ago ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
Published on 05/13/2026 at 17:45, 1 hour 9 minutes ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
